Which gives us upside of exactly 400% from where we are now.
Alot going well.....
I think there are 72 million shares fully diluted, so that equates to about $8.30 per share. I would certainly take it.
I would have agreed with you on that prior to the dilution but now I see it as half of that.
Rayos could become a 1billion $ drug within a few years. 600 million is a low estimation, prior to dilution, target mcap was more then 1 billion after R drug and D drug approved worldwide. .. I still think that 600 million is very modest